New anti-blood clotting drug may lower risk of recurrent strokes

An experimental drug designed to block blood-clotting proteins may lower the risk of recurrent strokes, according to a dose-finding trial published in The Lancet Neurology.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart